(Registrant’s telephone number, including area code)
Not Applicable
(Former
name or former address, if changed since last report).
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
i☐
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
i☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
i☐
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
i☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company i☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities registered pursuant to Section 12(b) of the Act:
Title
of each class
Trading symbol
Name of each exchange on which registered
iCommon Shares, Par Value $1.00 per share
iRNR
iNew
York Stock Exchange
iDepositary Shares, each representing a 1/1,000th interest in a Series F 5.750% Preference Share, Par Value $1.00 per share
iRNR PRF
iNew
York Stock Exchange
iDepositary Shares, each representing a 1/1,000th interest in a Series G 4.20% Preference Share, Par Value $1.00 per share
iRNR PRG
iNew
York Stock Exchange
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On March 31, 2023, RenaissanceRe Holdings Ltd. (the “Company”) announced that Ian Branagan, Executive Vice President and Group Chief Risk Officer of the Company, will take a compassionate leave of absence beginning April 1, 2023 (the “Leave”) and will return on July 3, 2023. For
the duration of the Leave, and in accordance with the Company’s standard policy, Mr. Branagan will continue to be employed by the Company but will cease to perform duties as an executive officer. Robin Lang, SVP and Head of Risk Oversight, who has been with the Company for 22 years, will serve as Interim Chief Risk Officer.
SIGNATURES
Pursuant to the requirements of the Securities Exchange
Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
